AP NEWS

Cystitis - Pipeline Insight, 2019 - ResearchAndMarkets.com

January 30, 2019

DUBLIN--(BUSINESS WIRE)--Jan 30, 2019--The “Cystitis - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Cystitis - Pipeline Insight, 2019 offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cystitis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

Clinical Non-clinical Inactive: Discontinued and/or Dormant

Scope of the report

The report provides a snapshot of the pipeline development for the Cystitis The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Cystitis The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cystitis The report also covers the dormant and discontinued pipeline projects related to Cystitis

Topics Covered

1. Report Introduction

2. Cystitis Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Cystitis

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities

7. Therapeutic Assessment

Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities

Companies Featured

Allergan Aquinox Pharmaceuticals Astellas Pharma Kytogenics Pharmaceuticals Lipella Pharmaceuticals MediPost UCB Urigen Pharmaceuticals UroGen Pharmaceuticals Gilead Sciences Bayer Pfizer

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/lvh32q/cystitis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190130005639/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Urological Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/30/2019 12:50 PM/DISC: 01/30/2019 12:50 PM

http://www.businesswire.com/news/home/20190130005639/en

AP RADIO
Update hourly